Phreesia Share Price (NYSE: PHR)

$31.66

▲

-0.89

(-2.73%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Phreesia Stock chart to analyse performance

Phreesia stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$31.40
Today's High:$32.70
$31.66
0.82%
Downside
Day's Volatility :3.96%
Upside
3.17%
52 Weeks Low:$17.07
52 Weeks High:$32.76
$31.66
46.08%
Downside
52 Weeks Volatility :47.89%
Upside
3.36%

Phreesia Stock Returns

Period	Phreesia, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	27.1%	3.6%	0.0%
6 Months	22.9%	-7.7%	0.0%
1 Year	33.03%	-12.6%	0.0%
3 Years	29.59%	9.5%	-4.7%

Phreesia, Inc. Key Stats

Check Phreesia key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$32.55
Open	$32.575
Today's High	$32.695
Today's Low	$31.4
Market Capitalization	$1.9B
Today's Volume	$695.7K
52 Week High	$32.76
52 Week Low	$17.07
Revenue TTM	$434.5M
EBITDA	$-19.8M
Earnings Per Share (EPS)	$-0.74
Profit Margin	-9.83%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-15.97%

Stock Returns calculator for Phreesia Stock including INR - Dollar returns

The Phreesia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Phreesia investment value today

Current value as on today

₹1,28,427

Returns

₹28,427

(+28.43%)

Returns from Phreesia Stock

₹23,143 (+23.14%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Phreesia Stock

257%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Phreesia Stock from India on INDmoney has increased by 257% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Phreesia, Inc.

Name
Holdings %
Name
Holdings %
FMR Inc
9.67%
BlackRock Inc
9.09%
Vanguard Group Inc
8.85%
Greenhouse Funds LLLP
5.59%
Capital Research & Mgmt Co - Division 3
5.27%
Champlain Investment Partners, LLC
4.58%

Analyst Recommendation on Phreesia Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 21 Wall street analysts offering stock ratings for Phreesia(by analysts ranked 0 to 5 stars)

Phreesia Share Price Target

What analysts predicted

Upside of 2.55%

Target:

$32.47

Current:

$31.66

Phreesia share price target is $32.47, a slight Upside of 2.55% compared to current price of $31.66 as per analysts' prediction.

Phreesia Stock Insights

Price Movement
In the last 7 days, PHR stock has moved up by 6.4%
Increasing Revenue
Revenue is up for the last 22 quarters, 32.81M → 115.93M (in $), with an average increase of 5.8% per quarter
Increasing Net Profit
Netprofit is up for the last 13 quarters, -51.24M → -3.91M (in $), with an average increase of 27.8% per quarter
PHR vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 61.6%
PHR vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 75.3%
Price to Sales
ForPHR every $1 of sales, investors are willing to pay $4.2, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Phreesia, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$124.8M	↑ 24.92%
Net Income	$-20.3M	↑ 34.73%
Net Profit Margin	-16.26%	↓ 1.18%

	FY21	Y/Y Change
Revenue	$148.7M	↑ 19.15%
Net Income	$-27.3M	↑ 34.49%
Net Profit Margin	-18.36%	↓ 2.1%

	FY22	Y/Y Change
Revenue	$213.2M	↑ 43.42%
Net Income	$-118.2M	↑ 332.95%
Net Profit Margin	-55.41%	↓ 37.05%

	FY23	Y/Y Change
Revenue	$280.9M	↑ 31.74%
Net Income	$-176.1M	↑ 49.07%
Net Profit Margin	-62.71%	↓ 7.3%

	FY24	Y/Y Change
Revenue	$356.3M	↑ 26.84%
Net Income	$-136.9M	↓ 22.29%
Net Profit Margin	-38.42%	↑ 24.29%

	FY25	Y/Y Change
Revenue	$419.8M	↑ 17.83%
Net Income	$-58.5M	↓ 57.24%
Net Profit Margin	-13.94%	↑ 24.48%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$95.0M	↑ 3.7%
Net Income	$-30.6M	↓ 4.05%
Net Profit Margin	-32.26%	↑ 2.6%

	Q2 FY24	Q/Q Change
Revenue	$101.2M	↑ 6.54%
Net Income	$-19.7M	↓ 35.65%
Net Profit Margin	-19.48%	↑ 12.78%

	Q3 FY24	Q/Q Change
Revenue	$102.1M	↑ 0.89%
Net Income	$-18.0M	↓ 8.67%
Net Profit Margin	-17.64%	↑ 1.84%

	Q4 FY24	Q/Q Change
Revenue	$106.8M	↑ 4.59%
Net Income	$-14.4M	↓ 20.04%
Net Profit Margin	-13.49%	↑ 4.15%

	Q1 FY25	Q/Q Change
Revenue	$109.7M	↑ 2.7%
Net Income	$-6.4M	↓ 55.63%
Net Profit Margin	-5.83%	↑ 7.66%

	Q2 FY25	Q/Q Change
Revenue	$115.9M	↑ 5.7%
Net Income	$-3.9M	↓ 38.75%
Net Profit Margin	-3.38%	↑ 2.45%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$80.1M	↑ 27.3%

	FY21	Y/Y Change
Profit	$96.3M	↑ 20.27%

	FY22	Y/Y Change
Profit	$131.8M	↑ 36.92%

	FY23	Y/Y Change
Profit	$171.6M	↑ 30.19%

	FY24	Y/Y Change
Profit	$232.3M	↑ 35.33%

	FY25	Y/Y Change
Profit	$284.9M	↑ 22.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$54.8M	↓ 9.73%

	Q2 FY24	Q/Q Change
Profit	$60.3M	↑ 10.14%

	Q3 FY24	Q/Q Change
Profit	$61.8M	↑ 2.45%

	Q4 FY24	Q/Q Change
Profit	$72.3M	↑ 16.91%

	Q1 FY25	Q/Q Change
Profit	$76.1M	↑ 5.33%

	Q2 FY25	Q/Q Change
Profit	$77.9M	↑ 2.31%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$826.0K	↓ 138.78%
Investing Cash Flow	$-12.3M	↑ 11.76%
Financing Cash Flow	$100.3M	↑ 2291.04%

	FY21	Y/Y Change
Operating Cash Flow	$2.9M	↑ 249.88%
Investing Cash Flow	$-25.1M	↑ 103.61%
Financing Cash Flow	$150.7M	↑ 50.26%

	FY22	Y/Y Change
Operating Cash Flow	$-74.7M	↓ 2685.12%
Investing Cash Flow	$-65.2M	↑ 160.03%
Financing Cash Flow	$235.0M	↑ 55.96%

	FY23	Y/Y Change
Operating Cash Flow	$-90.1M	↑ 20.63%
Investing Cash Flow	$-26.2M	↓ 59.83%
Financing Cash Flow	$-20.4M	↓ 108.68%

	FY24	Y/Y Change
Operating Cash Flow	$-32.4M	↓ 64.07%
Investing Cash Flow	$-39.7M	↑ 51.39%
Financing Cash Flow	$-17.1M	↓ 16.13%

	FY25	Y/Y Change
Operating Cash Flow	$32.4M	↓ 200.01%
Investing Cash Flow	$-24.1M	↓ 39.28%
Financing Cash Flow	$-11.5M	↓ 32.89%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-2.8M	↓ 55.18%
Investing Cash Flow	$-8.2M	↓ 48.09%
Financing Cash Flow	$-4.9M	↑ 112.78%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-873.0K	↓ 69.13%
Investing Cash Flow	$-5.4M	↓ 33.24%
Financing Cash Flow	$-1.7M	↓ 65.58%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$11.1M	↓ 1367.01%
Investing Cash Flow	$-7.4M	↑ 35.93%
Financing Cash Flow	$-1.4M	↓ 17.45%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$5.8M	↓ 47.7%
Investing Cash Flow	$-4.2M	↓ 43.51%
Financing Cash Flow	$-1.7M	↑ 19.55%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$16.3M	↑ 181.0%
Investing Cash Flow	$-7.1M	↑ 68.77%
Financing Cash Flow	$-6.6M	↑ 301.51%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$14.9M	↓ 8.65%
Investing Cash Flow	$-7.4M	↑ 4.73%
Financing Cash Flow	$-838.0K	↓ 87.36%

Phreesia Technicals Summary

Sell

Neutral

Buy

Phreesia is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Phreesia, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Phreesia, Inc.	17.43%	22.9%	33.03%	29.59%	-0.81%
Tempus Ai	38.06%	48.79%	45.48%	88.27%	88.27%
Doximity, Inc.	18.52%	-0.73%	89.28%	107.86%	28.21%
Ge Healthcare Technologies Inc.	5.57%	-14.7%	-13.04%	21.9%	21.9%
Veeva Systems Inc.	-4.29%	22.99%	24.82%	57.09%	-8.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Phreesia, Inc.	NA	NA	NA	0.08	-0.16	-0.06	NA	4.75
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Phreesia, Inc.	Buy	$1.9B	-0.81%	NA	-9.83%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-8.43%	55.28	27.29%

About Phreesia, Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Organization	Phreesia
Employees	2082
CEO	Mr. Chaim Indig
Industry	Technology Services

Key Management of Phreesia, Inc.

Name	Title
Mr. Chaim Indig	Co-Founder, CEO & Director
Mr. Evan Roberts	Co-Founder & President of Provider Solutions
Mr. Balaji Gandhi	Chief Financial Officer
Ms. Allison C. Hoffman J.D.	General Counsel & Secretary
Mr. David Linetsky	President of Network Solutions
Ms. Yvonne Hui	VP & Principal Accounting Officer
Mr. Jack Callahan	Chief Technology Officer
Ms. Maureen McKinney	Vice President of Corporate Communications
Ms. Amy Beth VanDuyn	Senior Vice President of Human Resources
Ms. Melissa Mitchell	Chief Privacy Officer

Important FAQs about investing in PHR Stock from India :

What is Phreesia share price today?

Phreesia share price today is $31.66 as on August 30, 2025 at 1:29 am IST at the close of the market. Phreesia share today touched a day high of $32.70 and a low of $31.40.

What is the 52 week high and 52 week low for Phreesia share?

Phreesia share touched a 52 week high of $32.76 and a 52 week low of $17.07. Phreesia stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $31.66, lower by 3.36% versus the 52 week high.

How to invest in Phreesia Stock (PHR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Phreesia on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phreesia Shares that will get you 0.0474 shares as per Phreesia share price of $31.66 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Phreesia Stock (PHR) from India?

Indian investors can start investing in Phreesia (PHR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Phreesia stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Phreesia share’s latest price of $31.66 as on August 30, 2025 at 1:29 am IST, you will get 0.3159 shares of Phreesia. Learn more about fractional shares .

What are the returns that Phreesia has given to Indian investors in the last 5 years?

Phreesia stock has given -0.81% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?